Kadance

Genomics-based precision health management embedded in life and critical illness insurance policies

Specialty Solutions Growth Seed

Overview

Kadance is a genomics-based precision health management platform for life, critical illness, and long-term care insurance carriers. The company partners with insurers to deliver genetic testing and clinical support programs as value-add benefits embedded in insurance policies, targeting policyholders at risk for hereditary cancers and adverse drug reactions.

The platform integrates three core services -- hereditary cancer risk assessment, pharmacogenomics testing, and personalized health navigation -- delivered as a living benefit rider or standalone consumer offering. Kadance operates its own genetic testing lab through its 2023 acquisition of Kailos Genetics, which has tested over 50,000 patients and detected more than seven million genetic variants. Clinical support is provided by oncology nurse navigators and molecular pathologists.

The company distributes through insurance carriers including Chubb, Nationwide, and Hannover Re. Kadance, formerly known as healthOme, rebranded in January 2025 and closed a Preferred Seed round in May 2024 led by American Family Ventures and AllegisNL Capital. A strategic investment from Nassau Financial Group followed in 2026.

Products & Services

Hereditary Cancer Risk Assessment

DNA-based testing to identify inherited cancer predispositions such as BRCA mutations and Lynch syndrome markers. Results inform personalized health management decisions for policyholders.

Key Features

Hereditary cancer gene panel testing
Actionable risk reports with clinical interpretation
Access to oncology nurse navigators for follow-up support

Target Users: Life and critical illness insurance policyholders

Pharmacogenomics Testing

Genetic analysis that determines how individuals respond to medications based on their DNA. The service identifies optimal drug selections and dosages to reduce adverse reactions.

Key Features

Multi-drug compatibility analysis
Medication efficacy and risk profiling
Clinical guidance on dosage optimization

Target Users: Insurance policyholders and healthcare consumers

Precision Health Management Program

An ongoing personalized health guidance program that integrates genetic insights with clinical consultation. Available as an insurance benefit rider or direct-to-consumer product.

Key Features

Integrated genomics testing and clinical navigation
Access to oncology nurse navigators and molecular pathologists
Available as insurance rider or consumer-direct subscription

Target Users: Life, critical illness, and long-term care insurance carriers and their policyholders

At a Glance

Founded: 2021
Headquarters: Huntsville, Alabama
Employees: 11-50
Funding: Seed

Category & Focus

Category: Specialty Solutions
Subcategories: Genomics-based health management living benefit riders pharmacogenomics
Insurance Verticals: Life & Annuity Group Benefits Reinsurance
Target Customers: Carriers, Reinsurers, Consumers